Trademark search for:

REGENEMAB

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2015-02-13 — Application filed
2015-03-19 — Sn assigned for sect 66a appl from ib
2015-03-20 — Application filed
2015-03-24 — Application filed
2015-05-21 — Assigned to examiner
2015-05-28 — Final disposition recorded
2015-05-29 — Office action issued
2015-05-29 — Office action issued
2015-05-29 — Office action issued
2015-06-21 — Office action issued
2015-10-23 — New representative at ib received
2015-12-29 — Assigned to examiner
2015-12-29 — Application abandoned
2015-12-29 — Application abandoned
2016-08-24 — Notification of possible opposition sent to ib
2016-08-24 — Notification of possible opposition created, to be sent to ib
2016-09-09 — Notification of possible opposition - processed by ib
2016-12-29 — Final disposition recorded
2016-12-29 — Final disposition recorded
2017-01-20 — Final disposition recorded
2025-02-13 — Final status recorded
2025-09-05 — Death of international registration

Owner Information

Regenesance B.V.
NL

Correspondent

V.O.
Johan de Wittlaan 7
NL-2517 JR Den Haag,
NETHERLANDS

Filing Details

Filing Date:
2015-02-13

Status Date:
2025-02-13

Category:
Pharmaceuticals

Filing Year:
2015

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.